Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.00bn	181.5	n/a
MSBMesoblast	AU$3.72bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$1.07bn	n/a	n/a
PYCPYC Therapeutics	AU$879.64m	n/a	n/a
IMMImmutep	AU$576.85m	n/a	n/a
RACRacura Oncology	AU$470.85m	n/a	n/a
CGSCogstate	AU$418.94m	28.12	0.8%
DXBDimerix	AU$335.17m	n/a	n/a
ACWActinogen Medical	AU$190.63m	n/a	n/a
TTXTetratherix	AU$168.61m	n/a	n/a
NYRNyrada	AU$158.19m	n/a	n/a
PEBPacific Edge	NZ$168.65m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$124.62m	n/a	n/a
ILAIsland Pharmaceuticals	AU$109.78m	n/a	n/a
LTPLtr Pharma	AU$94.11m	n/a	n/a
BXNBioxyne	AU$90.92m	18.42	n/a
ALAArovella Therapeutics	AU$90.33m	n/a	n/a
PIQProteomics International Laboratories	AU$83.40m	n/a	n/a
PTXPrescient Therapeutics	AU$73.28m	n/a	n/a
ATHAlterity Therapeutics	AU$73.02m	n/a	n/a